By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aduro Biotech 

626 Bancroft Way
Suite 3C
Berkeley  California  94710  U.S.A.
Phone: 510-848-4400 Fax: n/a




Company News
Aduro Biotech (ADRO) Confirms All Clinical Trials Continue Unaltered And As Planned 11/25/2015 10:05:33 AM
Aduro Biotech (ADRO) Drops After Quietly Disclosing Patient in Top Phase II Program Developed Serious Infection 11/24/2015 11:57:08 AM
Aduro Biotech (ADRO) Announces Third Quarter 2015 Financial Results 11/23/2015 10:26:18 AM
Aduro Biotech (ADRO) Receives Orphan Drug Designation In The European Union For CRS-207 For The Treatment Of Mesothelioma 11/23/2015 10:24:09 AM
Aduro Biotech (ADRO) Europe‚Äôs Chief Scientific Officer, Andrea Van Elsas, Ph.D. Featured As Keynote Speaker On Immunomodulatory Antibodies At ESMO Symposium On Immuno-Oncology 2015 11/20/2015 9:41:23 AM
Aduro Biotech (ADRO) Establishes European Subsidiary 11/20/2015 7:51:41 AM
Aduro Biotech (ADRO) Receives Milestone Payment From Janssen Pharmaceutical For Submission Of Investigational New Drug Application For ADU-741 In Prostate Cancer 11/18/2015 7:26:03 AM
Aduro Biotech (ADRO) Announces Five Poster Presentations At The Society Of Immunotherapy Of Cancer Annual Meeting 11/9/2015 11:59:12 AM
Aduro Biotech (ADRO) To Present At Credit Suisse Healthcare Conference 11/5/2015 10:34:29 AM
Aduro Biotech (ADRO) Receives Milestone Payment From Janssen Biotech Inc. (JNJ) For Acceptance Of Investigational New Drug Application For ADU-214 In Lung Cancer 10/29/2015 11:38:21 AM